首页 | 本学科首页   官方微博 | 高级检索  
     


Ledipasvir/sofosbuvir for treatment of hepatitis C virus in sofosbuvir‐experienced,NS5A treatment‐naïve patients: Findings from two randomized trials
Authors:Edward Tam  Anne F. Luetkemeyer  Parvez S. Mantry  Sanjaya K. Satapathy  Peter Ghali  Minhee Kang  Richard Haubrich  Xianlin Shen  Liyun Ni  Gregory Camus  Amanda Copans  Lorenzo Rossaro  Bill Guyer  Robert S. Brown Jr  the RESCUE  ACTG A study investigators
Affiliation:1. LAIR Centre, Vancouver, BC, Canada;2. Department of Medicine, University of California, San Francisco, CA, USA;3. The Liver Institute, Methodist Dallas Medical Center, Dallas, TX, USA;4. Methodist University Hospital Transplant Institute, University of Tennessee Health Sciences Center, Memphis, TN, USA;5. McGill University Health Centre, Royal Victoria Hospital, Montreal, QC, Canada;6. Harvard T.H. Chan School of Public Health, Boston, MA, USA;7. Gilead Sciences, Foster City, CA, USA;8. Division of Gastroenterology and Hepatology, Weill Cornell Medical College, New York City, NY, USA
Abstract:
Keywords:HCV  HIV  ledipasvir  sofosbuvir  treatment‐experienced
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号